Affiliation:
1. A.I. Evdokimov Moscow State University of Medicine and Dentistry
Abstract
Recently, in the clinical practice of treating hepatobiliary diseases, significant progress has been made in understanding the molecular basis of bile formation and cholestasis pathophysiology. This article briefly summarizes the modern concepts of bile formation and cholestasis. The goals of drug therapy for cholestasis have been determined, which help to understand existing methods of treating cholestasis and contribute to the development of new agents for cholestatic liver diseases.
Reference21 articles.
1. Ivashkin VT, Shirokova EN, Mayevskaya MV, et al. Clinical recommendations of the Russian Gastroenterological Association and the Russian Society for the Study of the Liver for the diagnosis and treatment of cholestasis. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2015;25(2):41-57. (In Russ.)
2. Yokoda RT, Rodriguez EA. Review: Pathogenesis of cholestatic liver diseases. World J Hepatol. 2020;12(8):423-35. doi:10.4254/wjh.v12.i8.423.
3. Polunina TE. Therapeutic approaches to the treatment of cholestatic liver diseases. Therapy. 2019;3:99-108. (In Russ.)
4. Sherlock S, Dooley J. Diseases of the liver and biliary tract. Moscow: Geotar Medicine. 1999. p. 859. (In Russ.)
5. Khungar V, Goldberg DS. Liver Transplantation for Cholestatic Liver Diseases in Adults. Clin Liver Dis. 2016;20:191-203. doi:10.1016/j.cld.2015.08.011.